Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AstraZeneca
Biotech
AstraZeneca buys partner Omniose for bacterial vaccine tech
AstraZeneca has acquired vaccine bioconjugation specialist Omniose, securing technology and expertise that could boost its work on bacterial threats.
Nick Paul Taylor
Nov 10, 2026 10:16am
Fierce Pharma
AZ’s reported $10B offer for Rhythm fuels talks of a bidding war
Nov 5, 2026 9:36am
AstraZeneca cuts early-phase prostate cancer pipeline
Oct 30, 2026 5:03am
ESMO: AZ exec insists ph. 3 ADC data ‘robust’ despite PFS miss
Oct 25, 2026 11:30am
AstraZeneca taps Oracle to improve recruitment for trials
Oct 20, 2026 2:36am
AstraZeneca, insitro ink $1.5B AI-enabled target discovery deal
Oct 15, 2026 6:00am